Loading company…
UK pharmaceutical company developing prescription medicines for targeted diseases affecting the Central Nervous System.
Syntropharma is a UK pharmaceutical company that develops prescription medicines for specifically targeted diseases of the Central Nervous System. It is listed at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in